| MEDA Pharma GmbH - Minitran 5, transdermales Pflaster |
| 51920 | | 01 | | Minitran 5 | | transdermales Pflaster | | C01DA02 | | Glyceroltrinitrat | | 22.01.1993 | | |
|
| Composition |
| glyceroli trinitras 18 mg, isooctyl acrylate/acrylamide copolymer (93:7), ethylis oleas, glyceroli monolauras, polyethylenum, ad praeparationem pro 6.7 cm² cum liberatione 5 mg/24h. |
| Packungsbestandteile |
| Transdermales Pflaster | | | | | Principe actif | Concentr. |
|---|
| Glyceroli Trinitras | 18 mg |
| | BAG: Principe actif | Concentr. |
|---|
| | 18 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| | 6.7 cm | | | 5mg / 24h | | | | | | | | | | | Polyethylenum | |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 023 | 30 Pflaster | 13.70 | 28.05 | B | | Non |
|
